维普期刊资源整合服务平台（V6.5）

164篇 您的检索式：作者名="Rusch V"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Narrowband interference suppression in CDMA spread spectrum communications 显示文摘	Rusch L A Poor H V	1994	IEEE Transactions on Communication1994，42，3：	1
2	Narrowband interference suppression in spread spectrum CDMA显示文摘	H V Poor L A Rusch	1994	IEEE Pets Commun1994，，3：	1
3	Molecular Characteristics Predict Clinical Outcomes: Prospective Trial Correlating Response to the EGFR Tyrosine Kinase Inhibitor Gefitinib with the Presence of Sensitizing Mutations in the Tyrosine Binding Domain of the EGFRGene 显示文摘	Rizvi NA Rusch V Pao W	2011	ClinCancerRes2011，17，10：	1
4	Narrowband interference suppression in CDMA spread spectrum communications显示文摘	Rusch L A Poor H V	1994	IEEE Trans Commun1994，42，4：	1
5	High telomerase activity in primary lung cancers:association with increased cell proliferation rates and advanced pathologic stage显示文摘	Albanell J Lonardo F Rusch V	1997	J Natl Cancer Inst1997，89，21：	1
6	High telomerase activity in primary lung cancers:association with increased cell proliferaion rates and advanced pa-thologicstage显示文摘	Albanell J Lonardo f Rusch V	1997	J Natl Cancer Inst1997，89，21：	1
7	Narrowband Interference Suppression in Spread Spectrum CDMA 显示文摘	Poor H V Rusch L A	1994	IEEE Personal Communication Magazine1994，，：	1
8	Factors influencing ten-year survival in resected stages I to III A non-small cell lung cancer显示文摘	MARTINI N RUSCH V W BAINS M S	1999	7 Thorac Cardiovasc Surg1999，117，1：	1
9	The novel oncogene CSSCCRO induces extracellular matrix invasion by matrix metalloproteinase-2 expression显示文摘	O-charoenrat P Reddy P Rusch V	2002	Proc Am Assoc Cancer Res2002，43，：	1
10	Phase trial of concurrent chemotherapy and radiotherapy ( CT / RT) vs CT / RT followed by surgical resection for stage Ⅲ a (PN2)non - small cell lung cancer (NSCLC):Outcome and implication for surgical management in North American Intergroup 0139 ( RTOG 9309) 显示文摘	RUSCH V ALBAIN K TURRISI A	2005	Lung Cancer2005，49，2：	1
11	Management of Pancoast tumours显示文摘	RUSCH V W	2006	Lancet Oneol2006，7，：	1
12	Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression显示文摘	Klimstra D Venkatraman E	1997	Clin Cancer Res1997，3，：	1
13	Narrowband interference suppression in CDMA spread spectrum communications显示文摘	RUSCH L A POOR H V	1994	IEEE Transaction on Communications1994，42，234：	1
14	Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung显示文摘	Baselga J Cordon-Cardo C	1993	Cancer Res1993，53，：	1
15	Molecular Characteristics Predict Clinical Outcomes: Prospective Trial Correlating Response to the EGFR Tyrosine Kinase Inhibitor Gefitinib with the Presence of Sen- sitizing Mutations in the Tyrosine Binding Domain of the EGFR Gene显示文摘	Rizvi NA Rusch V Pao W	2011	Ciin Caucer Res2011，17，10：	1
16	Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several 显示文摘	Rusch V W	2004	Semin Oncol2004，31，4：	1
17	Proposed revision of the staging classification for esophageal cancer 显示文摘	KORST R J RUSCH V W VENKATRAMAN E	1998	J Thorac Cardiovasc Surg1998，115，3：	1
18	Casein kinase Ⅱ alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung显示文摘	O-charoenrat P Rusch V Talbot SG	2004	Clin Cancer Res2004，10，17：	1
19	Surgery for Bronchioloalveolar Carcinoma and Very Early Adenocarcinoma:An Evolving Standard of Care?显示文摘	RUSCH V W TSUCHIYA R TSUBOI M	2006	J Thorac Oncol2006，1，91：	1
20	Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development 显示文摘	Lonardo F Rusch V Langenfeld J	1999	Cancer Res1999，59，10：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示